HeartMate 3 Use Postapproval Is Soaring—and Equitably, New Numbers Show
Fewer Black patients underwent transplant by 1 year, but for those who got a heart, outcomes didn’t differ by gender or race.
Stay updated with breaking news from Abbott Cardiovascular. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Fewer Black patients underwent transplant by 1 year, but for those who got a heart, outcomes didn’t differ by gender or race.
The Amulet and Watchman FLX devices for left atrial appendage closure produced equivalent results, with about half of patients having residual patency of the appendage at 13 months, a study shows.
With complication rates of 1% or less, Neuroguard and CGuard are renewing optimism about CAS, experts said at VIVA 2023.
Aghast at the sheer volume of plastic waste and packaging after a simple PCI, Richard Bogle wants companies to find real solutions.
/PRNewswire/ -- ABILITY DIABETES-GLOBAL (ADG), is the World's largest Randomized Controlled Trial (RCT) for patients with DM (Diabetes Mellitus), comparing...